Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest to Acquire U.S. Marketing Rights to Saphris® (asenapine) from Merck
Yahoo
Monday, December 2, 2013 - 10:17am
tags:
Saphris, schizophrenia, Forest Labs, Merck
Biogen Idec says FDA will allow 3 more months to review its hemophilia B drug Alprolix
Yahoo/AP
Monday, December 2, 2013 - 10:15am
tags:
Biogen Idec, FDA, hemophilia B, Alprolix
Baxter submits amended BLA to U.S. FDA for HyQvia
The Fly on the Wall
Monday, December 2, 2013 - 10:13am
tags:
Baxter International, FDA, HyQvia, Halozyme
Forest Labs Unveils Restructuring Plan
NASDAQ.com
Monday, December 2, 2013 - 9:51am
tags:
Forest Labs, restructuring, layoffs
Johnson & Johnson's Real Answer To Imminent Decline In Sales Of Top-Selling Drug
Seeking Alpha
Monday, December 2, 2013 - 9:45am
tags:
JNJ, Remicade, Olysio, hepatitis C
Is GlaxoSmithKline plc Set For Electrifying Earnings Growth In 2014?
Motley Fool
Monday, December 2, 2013 - 9:43am
tags:
GSK
The Growing Need For Outcome Studies And The Impact On R&D Costs
Forbes
Monday, December 2, 2013 - 9:42am
tags:
clinical outcomes, R&D, PCSK9 inhibitors
If Northwest Biotherapeutics Wins, It Wins Big
Seeking Alpha
Monday, December 2, 2013 - 8:44am
tags:
Northwest Biotherapeutics, DCVax, brain cancer, solid tumors
Biotech Stocks Partying Like It's 1999
TheStreet.com
Monday, December 2, 2013 - 8:42am
tags:
biotech
GSK says CEO's China visit flags commitment in face of graft scandal
Reuters
Monday, December 2, 2013 - 8:40am
tags:
GSK, China
Shire agrees to supply Adderall XR generic to Sandoz
Reuters
Monday, December 2, 2013 - 8:40am
tags:
Shire, generics, Sandoz, Novartis, ADHD, Adderall XR
GSK stalwart gets key post at Takeda
Pharma Times, UK
Monday, December 2, 2013 - 8:38am
tags:
GSK, Takeda, Christophe Weber
Pfizer Acquires Polocard, Poland’s Leading Over-The-Counter Heart Attack Prevention Brand
Yahoo
Monday, December 2, 2013 - 8:35am
tags:
Pfizer, M&A, Polocard, Poland, heart attacks
Pfizer Stock: 3 Things to Know Before 2014
Motley Fool
Monday, December 2, 2013 - 8:34am
tags:
Pfizer, RN-316, palbociclib, Xalkori
NanoViricides reports safety profile of its FluCide drug candidate
The Fly on the Wall
Monday, December 2, 2013 - 8:32am
tags:
NanoViricides, FluCide, Flu
November's 3 Biggest Biotech Busts
Motley Fool
Monday, December 2, 2013 - 8:31am
tags:
Immunogen, Aegerion, eteplirsen, Sarepta Therapeutics
Galena: A Pipeline Rich For Investors
Seeking Alpha
Monday, December 2, 2013 - 8:29am
tags:
Galena Biopharma, INSYS Therapeutics, Biomarin, NeuVax
Any Hopes Left For Amarin Bulls?
Seeking Alpha
Sunday, December 1, 2013 - 10:38am
tags:
Amarin
Is There More to Isis Pharmaceuticals Than Kynamro?
Motley Fool
Sunday, December 1, 2013 - 10:37am
tags:
Isis Pharmaceuticals
Akorn Survives Near-Death Experience With New Leaders
investors.com
Sunday, December 1, 2013 - 10:28am
tags:
Akorn

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.